This review examines how microfluidics has been used in the formulation, preclinical, and clinical development of gene-delivery nanoparticles.
R. James Taylor
Advertisement
R. James Taylor, PhD, is CEO and co-founder at Precision Nanosystems.
Articles by R. James Taylor
Advertisement
Latest Updated Articles
Accelerating Genetic Medicine R&D Using MicrofluidicsSeptember 15th 2017
Advertisement
Advertisement